Omvoh® (mirikizumab-mrkz) HCP

Omvoh® (mirikizumab-mrkz) hcp email format

Verified email-pattern data for Omvoh® (Mirikizumab-Mrkz) Hcp is currently limited. You can still use the company insights and contact sections below.
Welcome! Check out our community guidelines at http://e.lilly/2Wnzrc6. See Prescribing Information at https://uspl.lilly.com/omvoh/omvoh.html?s=pi, Medication Guide at https://uspl.lilly.com/omvoh/omvoh.html?s=mg and Instructions for Use at https://uspl.lilly.com/omvoh/omvoh.html?s=ug0 To report an adverse event or product complaints, please contact The Lilly Answers Center at 1-800-LillyRx
(1-800-545-5979). PP-MR-US-0286 01/2025 ©Lilly USA, LLC 2023. All rights reserved.
Looking for a particular Omvoh® (mirikizumab-mrkz) HCP employee's phone or email?

Omvoh® (Mirikizumab-Mrkz) Hcp Questions

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant